Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04192591 · ClinicalTrials.gov registry record · NA

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

A NA study of Lumbar Spinal Stenosis, sponsored by Boston Scientific Corporation.

Active
Registry status
NA
Development phase
166
Enrollment target
20
Study locations

NCT04192591 is a NA study of Lumbar Spinal Stenosis that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 166 participants, below the 660-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (75% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04192591, a NA study of Lumbar Spinal Stenosis, is active but no longer recruiting, sponsored by Boston Scientific Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
166 participants
Enrollment target
20
Study locations

Study Summary

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Conditions Studied

Lumbar Spinal Stenosis

Interventions

  • DEVICE Superion™ IDS device

Study Locations (20)

California

  • Coastal Research Institute, LLC - Carlsbad
  • MarinHealth Spine Institute - Larkspur
  • Vitamed Research - Rancho Mirage
  • IPM Medical Group Inc. - Walnut Creek

Florida

  • Holy Cross Hospital - Fort Lauderdale
  • The Orthopaedic Institute - Gainesville

Georgia

  • Alliance Spine and Pain Centers - Atlanta
  • Centurion Spine and Pain - Waycross

Illinois

  • Rush University Medical Center - Chicago
  • Ascension Alexian Brothers - Elk Grove Village

Kansas

  • University of Kansas Hospital - Kansas City
  • Neuroscience Research Center, LLC - Overland Park

Idaho

  • North Idaho Day Surgery - Post Falls

Massachusetts

  • Brigham and Women's Hospital - Boston

Michigan

  • Michigan Pain Specialists - Ypsilanti

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2020-01-30
Est. Completion 2041-02
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04192591

The ClinicalTrials.gov registry entry for NCT04192591 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 660-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (75% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lumbar Spinal Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Superion™ IDS device is the first listed.

NCT04192591 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT04192591 about?

NCT04192591 is a clinical study titled "A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)". To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

What is the current status of trial NCT04192591?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 166 participants. The study started on 2020-01-30. Estimated completion is 2041-02.

What conditions does trial NCT04192591 study?

This clinical trial studies the following conditions: Lumbar Spinal Stenosis.

What interventions are being tested in trial NCT04192591?

The interventions under investigation include: Superion™ IDS device (DEVICE).

Who is sponsoring clinical trial NCT04192591?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04192591 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lumbar Spinal Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lumbar Spinal Stenosis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.